ThePharm
Board
1 director, last change in 2023Director, permanent representative
since 28-09-2022
term without a fixed end
listed in the 2025 annual accounts, filed on 30-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “11.3. Vertegenwoordiging Iedere bestuurder vertegenwoordigt de vennootschap jegens derden en in rechte als eiser of als verweerder. De…”deed of 02-08-2023
Permanent representatives 1
Mandates through the years
4 names, the dashed line is todayDirector
Manager
Manager
Statutory manager
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
-
- Director, from 28-09-2022 to date
-
- Manager, appointed by deed of 21-03-2018, until 28-09-2022
- Manager, appointed by deed of 21-03-2018, no longer listed in the 2025 annual accounts
-
- Manager, until 21-03-2018
-
- Statutory manager, until 24-01-2017
Control
Parent
Equity €909,343
Profit €251,061 in 2025 (profit €231,501 in 2024)
Checked score
100%
This company
ThePharm
Equity €268,374
Profit €112,397 in 2025
Capital
- Contribution
- €239,592.01
- Shares
- 2,822 in the deed of 24-01-2017 and 1 later capital increase
- Contribution per share
- €84.90
- Equity per share
- €95.10 in 2025
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
-
- 2022: consolidates
- 2023: 100%
- 2024: consolidates
- 2025: 100%
-
- 2010: 100%
- 2011 to 2017: 99%
Source: parent in its own accounts, lists of holdings in the owners' accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 02-08-2023 (in Dutch)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Wednesday of June at 18:00deed of 24-04-2025 (in Dutch)
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one.
- No statutory auditordeed of 02-08-2023 (in Dutch)
Shareholders
2 ownersOwners 2
- parentEquity €909,343 Profit of €251,061 in 2025 (profit of €231,501 in 2024) Checked scoreSourceaccounts 2025100%
- Sourceown accounts 2018share not stated
Capital transactions
Shareholders according to the deeds
After the capital increase
deed of 25-01-2018 ↗
- 2,028 shares · €190,000 in cash
Stated in the deed
deed of 24-11-2016 ↗
- 499 shares
- 1 share
Capital over time
- 02-08-2023 Converted to available equity
- 25-01-2018 Capital increase of €190,000 · to €264,393.18 · 2,028 new shares
- 24-01-2017 Capital increase of €55,800 · to €74,392.01 · 294 new shares, 37% of the 794 shares after the increase
- 24-11-2016 Capital stated in the deed · €18,592.01 · 500 shares